Published in N Engl J Med on March 11, 1993
Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci U S A (1999) 4.88
The new genetics in clinical practice. BMJ (1998) 2.95
Neonatal diabetes mellitus. Endocr Rev (2008) 2.64
Genomewide search for type 2 diabetes susceptibility genes in four American populations. Am J Hum Genet (2000) 2.19
An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. J Clin Invest (1998) 2.18
Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J Clin Invest (2005) 2.14
Mammalian glucokinase and its gene. Biochem J (1993) 2.11
Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes. Nat Genet (2013) 1.91
The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes. Diabetologia (2012) 1.89
Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus. J Clin Invest (1999) 1.89
Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest (1994) 1.82
Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1alpha knockout mouse. Mol Cell Biol (1998) 1.81
Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev (2008) 1.66
Mapping of murine diabetogenic gene mody on chromosome 7 at D7Mit258 and its involvement in pancreatic islet and beta cell development during the perinatal period. J Clin Invest (1998) 1.65
Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J Clin Invest (1996) 1.58
Glucokinase as pancreatic beta cell glucose sensor and diabetes gene. J Clin Invest (1993) 1.55
Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: a sequestration mechanism in metabolic regulation. Proc Natl Acad Sci U S A (1999) 1.37
Genomewide search for type 2 diabetes mellitus susceptibility loci in Finnish families: the Botnia study. Am J Hum Genet (2002) 1.31
Molecular targets of a human HNF1 alpha mutation responsible for pancreatic beta-cell dysfunction. EMBO J (2000) 1.31
Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect. J Clin Invest (1997) 1.30
Variable effects of maturity-onset-diabetes-of-youth (MODY)-associated glucokinase mutations on substrate interactions and stability of the enzyme. Biochem J (1995) 1.30
Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth. J Clin Endocrinol Metab (2013) 1.26
S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin. Am J Pathol (2000) 1.18
Mutations at the BLK locus linked to maturity onset diabetes of the young and beta-cell dysfunction. Proc Natl Acad Sci U S A (2009) 1.17
Genetic evidence that HNF-1alpha-dependent transcriptional control of HNF-4alpha is essential for human pancreatic beta cell function. J Clin Invest (2002) 1.16
Growth factor control of pancreatic islet regeneration and function. Pediatr Diabetes (2008) 1.16
Association of GCKR rs780094, alone or in combination with GCK rs1799884, with type 2 diabetes and related traits in a Han Chinese population. Diabetologia (2009) 1.15
Defining a comprehensive verotype using electronic health records for personalized medicine. J Am Med Inform Assoc (2013) 1.13
Developmental origins of adult disease. Pediatr Clin North Am (2009) 1.13
Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects. PLoS One (2010) 1.10
Insulin receptor substrate-1 variants in non-insulin-dependent diabetes. J Clin Invest (1994) 1.09
Functional analyses of the mutation nt-128 T→G in the hepatocyte nuclear factor-1α promoter region in Chinese diabetes pedigrees. Diabet Med (2012) 1.09
Structural instability of mutant beta-cell glucokinase: implications for the molecular pathogenesis of maturity-onset diabetes of the young (type-2). Biochem J (1997) 1.07
A missense mutation in hepatocyte nuclear factor-4 alpha, resulting in a reduced transactivation activity, in human late-onset non-insulin-dependent diabetes mellitus. J Clin Invest (1998) 1.06
Genetics of gestational diabetes mellitus and type 2 diabetes. Diabetes Care (2007) 1.03
Glucokinase and cytosolic phosphoenolpyruvate carboxykinase (GTP) in the human liver. Regulation of gene expression in cultured hepatocytes. J Clin Invest (1995) 1.03
Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies. PLoS One (2013) 1.02
Phenotype variability and neonatal diabetes in a large family with heterozygous mutation of the glucokinase gene. Acta Diabetol (2011) 1.01
The nucleosome binding protein HMGN3 modulates the transcription profile of pancreatic beta cells and affects insulin secretion. Mol Cell Biol (2009) 1.00
Exome sequencing and genetic testing for MODY. PLoS One (2012) 1.00
Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands. J Clin Invest (1998) 1.00
The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) Project: rationale and planned nationwide studies of genetic predictors, physical exercise, and individualized pharmacological treatment. Clin Epidemiol (2012) 0.99
Additive effects of genetic variation in GCK and G6PC2 on insulin secretion and fasting glucose. Diabetes (2009) 0.99
Conformational transition pathway in the allosteric process of human glucokinase. Proc Natl Acad Sci U S A (2006) 0.97
Clinical heterogeneity in monogenic diabetes caused by mutations in the glucokinase gene (GCK-MODY). Diabetes Care (2009) 0.96
Cost-effectiveness of MODY genetic testing: translating genomic advances into practical health applications. Diabetes Care (2013) 0.94
Autoantibodies against CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) that impair glucose-induced insulin secretion in noninsulin- dependent diabetes patients. J Clin Invest (1998) 0.93
New opportunities: harnessing induced pluripotency for discovery in diabetes and metabolism. Cell Metab (2013) 0.90
SUMOylation of pancreatic glucokinase regulates its cellular stability and activity. J Biol Chem (2013) 0.89
Hepatic function in a family with a nonsense mutation (R154X) in the hepatocyte nuclear factor-4alpha/MODY1 gene. J Clin Invest (1997) 0.89
Deletion of the donor splice site of intron 4 in the glucokinase gene causes maturity-onset diabetes of the young. J Clin Invest (1993) 0.89
Dominant form of congenital hyperinsulinism maps to HK1 region on 10q. Horm Res Paediatr (2013) 0.87
Obesity and hyperinsulinemia in a family with pancreatic agenesis and MODY caused by the IPF1 mutation Pro63fsX60. Transl Res (2010) 0.86
Glucokinase activity in the arcuate nucleus regulates glucose intake. J Clin Invest (2014) 0.86
Genetic polymorphism of glucokinase on the risk of type 2 diabetes and impaired glucose regulation: evidence based on 298,468 subjects. PLoS One (2013) 0.85
Differential expression of genes and changes in glucose metabolism in the liver of liver-specific glucokinase gene knockout mice. Gene (2013) 0.85
Retinoids synergize with insulin to induce hepatic Gck expression. Biochem J (2009) 0.84
Metabolic signals trigger glucose-induced inactivation of maltose permease in Saccharomyces. J Bacteriol (2000) 0.84
Hepatic glucokinase promoter polymorphism is associated with hepatic insulin resistance in Asian Indians. BMC Genet (2000) 0.83
Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia. PLoS One (2012) 0.83
A defective beta-cell glucose sensor as a cause of diabetes. N Engl J Med (1993) 0.82
Lys169 of human glucokinase is a determinant for glucose phosphorylation: implication for the atomic mechanism of glucokinase catalysis. PLoS One (2009) 0.82
Regulatory effects of glucose on the catalytic activity and cellular content of glucokinase in the pancreatic beta cell. Study using cultured rat islets. J Clin Invest (1994) 0.82
Non-insulin dependent diabetes mellitus in Mexican-American children. West J Med (1998) 0.81
Genetic Counseling for Diabetes Mellitus. Curr Genet Med Rep (2014) 0.79
Mutations in KCNJ11 are associated with the development of autosomal dominant, early-onset type 2 diabetes. Diabetologia (2013) 0.79
β-cell mass in people with type 2 diabetes. J Diabetes Investig (2011) 0.78
Genetic dissection of complex genetic factor involved in NIDDM of OLETF rat. Exp Diabetes Res (2012) 0.78
GCK-MODY diabetes associated with protein misfolding, cellular self-association and degradation. Biochim Biophys Acta (2012) 0.78
Conformational transition pathway in the activation process of allosteric glucokinase. PLoS One (2013) 0.78
Genetic testing for maturity onset diabetes of the young in childhood hyperglycaemia. Arch Dis Child (1998) 0.78
Insight into the biochemical characteristics of a novel glucokinase gene mutation. Hum Genet (2010) 0.77
Chromosome 7p linkage and association study for diabetes related traits and type 2 diabetes in an African-American population enriched for nephropathy. BMC Med Genet (2010) 0.77
In situ glucose uptake and glucokinase activity of pancreatic islets in diabetic and obese rodents. J Clin Invest (1994) 0.77
Inhibition of Small Maf Function in Pancreatic β-Cells Improves Glucose Tolerance Through the Enhancement of Insulin Gene Transcription and Insulin Secretion. Endocrinology (2015) 0.77
Molecular diagnosis of maturity onset diabetes of the young in India. Indian J Endocrinol Metab (2013) 0.76
Variants of the HNF1α gene: A molecular approach concerning diabetic patients from southern Brazil. Genet Mol Biol (2012) 0.76
Insulinization: A promising strategy for the treatment of type 2 diabetes mellitus. Exp Ther Med (2013) 0.76
Impact of family history of diabetes on β-cell function and insulin resistance among Chinese with normal glucose tolerance. Diabetes Technol Ther (2012) 0.76
SEL1L regulates adhesion, proliferation and secretion of insulin by affecting integrin signaling. PLoS One (2013) 0.76
A new compound heterozygosis for inactivating mutations in the glucokinase gene as cause of permanent neonatal diabetes mellitus (PNDM) in double-first cousins. Diabetol Metab Syndr (2015) 0.75
Genetics of common disease: implications for therapy, screening and redefinition of disease. Philos Trans R Soc Lond B Biol Sci (1997) 0.75
Roles of Vitamin A Metabolism in the Development of Hepatic Insulin Resistance. ISRN Hepatol (2013) 0.75
Polymorphism of glucokinase gene in non-insulin dependent diabetes mellitus. Korean J Intern Med (1994) 0.75
Arcuate nucleus glucokinase and dietary glucose intake. Oncotarget (2015) 0.75
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med (2009) 7.53
Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1) Nature (1996) 6.72
CARD15 mutations in Blau syndrome. Nat Genet (2001) 5.79
Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3) Nature (1996) 5.32
Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet (1996) 4.84
Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J Immunol (1998) 4.74
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
A novel reporter mouse strain that expresses enhanced green fluorescent protein upon Cre-mediated recombination. FEBS Lett (2000) 4.03
G protein-coupled inwardly rectifying K+ channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons. Neuron (1997) 3.52
Molecular biology of mammalian glucose transporters. Diabetes Care (1990) 3.33
The state and fate of Himalayan glaciers. Science (2012) 3.33
Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J (1999) 3.19
beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. Nat Genet (2002) 3.12
Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab (2003) 3.10
Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature (1992) 2.86
The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science (1993) 2.77
Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res (1999) 2.74
Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility. BMJ (2001) 2.74
Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism. Nat Genet (2001) 2.73
Ecological genomics of marine Roseobacters. Appl Environ Microbiol (2007) 2.68
Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. Br Med J (Clin Res Ed) (1987) 2.67
Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature (1992) 2.59
Efficient chromosomal transposition of a Tc1/mariner- like transposon Sleeping Beauty in mice. Proc Natl Acad Sci U S A (2001) 2.51
Transmission/disequilibrium tests using multiple tightly linked markers. Am J Hum Genet (2000) 2.45
Sequence and functional characterization of a third inositol trisphosphate receptor subtype, IP3R-3, expressed in pancreatic islets, kidney, gastrointestinal tract, and other tissues. J Biol Chem (1993) 2.42
Fructose transporter in human spermatozoa and small intestine is GLUT5. J Biol Chem (1992) 2.35
Case-only design to measure gene-gene interaction. Epidemiology (1999) 2.30
Genetic analyses of chromosome 12 loci in Crohn's disease. Gut (2000) 2.30
Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet (1995) 2.29
Abnormalities of PIG-A transcripts in granulocytes from patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med (1994) 2.27
Regulation of a transcription factor network required for differentiation and metabolism. Science (1998) 2.22
Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11778 or 14484 mutations on an mtDNA lineage. Am J Hum Genet (1997) 2.21
Requirement of DNase II for definitive erythropoiesis in the mouse fetal liver. Science (2001) 2.17
A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet (2001) 2.17
Structure and function of mammalian facilitative sugar transporters. J Biol Chem (1993) 2.14
Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response. Nat Cell Biol (1999) 2.14
Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers. Neurology (2012) 2.12
Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase). Proc Natl Acad Sci U S A (1998) 2.12
Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes (2001) 2.08
Developmental abnormalities of glycosylphosphatidylinositol-anchor-deficient embryos revealed by Cre/loxP system. Lab Invest (1999) 2.06
The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia (2002) 1.99
Alteplase for hepatic veno-occlusive disease complicating bone-marrow transplantation. Lancet (1992) 1.99
Tissue-specific knockout of the mouse Pig-a gene reveals important roles for GPI-anchored proteins in skin development. Proc Natl Acad Sci U S A (1997) 1.97
Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young. Lancet (1992) 1.95
Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ (1988) 1.91
Normal cerebellar development but susceptibility to seizures in mice lacking G protein-coupled, inwardly rectifying K+ channel GIRK2. Proc Natl Acad Sci U S A (1997) 1.88
Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes (1995) 1.87
Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative. J Immunol (1988) 1.86
Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice. J Clin Invest (1998) 1.86
Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes (1994) 1.85
Multicentre evaluation of the DCA 2000 system for measuring glycated haemoglobin. DCA 2000 Study Group. Diabetes Metab (1997) 1.82
Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest (1994) 1.82
Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells. Mol Cell Biol (1997) 1.80
Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J (1994) 1.80
Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proc Natl Acad Sci U S A (1993) 1.77
A multidisciplinary study of patients with early-onset PD with and without parkin mutations. Neurology (2008) 1.74
Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest (1997) 1.71
Beta-aminoglutaric acid is a major soluble component of Methanococcus thermolithotrophicus. Biochim Biophys Acta (1989) 1.69
Epidemiology and factor analysis of obesity, type II diabetes, hypertension, and dyslipidemia (syndrome X) on the Island of Kosrae, Federated States of Micronesia. Hum Hered (2001) 1.67
The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes. Nat Genet (2000) 1.65
Expression cloning of PIG-L, a candidate N-acetylglucosaminyl-phosphatidylinositol deacetylase. J Biol Chem (1997) 1.65
Regulation of wingless-type MMTV integration site family (WNT) signalling in pancreatic islets from wild-type and obese mice. Diabetologia (2009) 1.65
Is glucose self-monitoring beneficial in non-insulin-treated diabetic patients? Results of a randomized comparative trial. Diabete Metab (1990) 1.64
Pancreatic beta cell-specific transcription of the pdx-1 gene. The role of conserved upstream control regions and their hepatic nuclear factor 3beta sites. J Biol Chem (2000) 1.64
On the use of population-based registries in the clinical validation of genetic tests for disease susceptibility. Genet Med (2001) 1.64
A novel protein that participates in nonself discrimination of malignant cells by homologous complement. Nat Med (1997) 1.61
Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes (1996) 1.60
Impaired glucose homeostasis and neonatal mortality in hepatocyte nuclear factor 3alpha-deficient mice. Proc Natl Acad Sci U S A (1999) 1.56
Transcription factor-dependent regulation of CBP and P/CAF histone acetyltransferase activity. EMBO J (2001) 1.55
Glycosylphosphatidylinositol-anchor-deficient mice: implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria. Blood (1996) 1.55
Glucokinase as pancreatic beta cell glucose sensor and diabetes gene. J Clin Invest (1993) 1.55
Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes (1995) 1.54
CFTR: covalent and noncovalent modification suggests a role for fixed charges in anion conduction. J Gen Physiol (2001) 1.53
Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27). Diabetologia (2012) 1.51
Molecular cloning of a murine homologue of membrane cofactor protein (CD46): preferential expression in testicular germ cells. Biochem J (1998) 1.50
microRNAs and the regulation of glucose and lipid metabolism. Diabetes Obes Metab (2007) 1.49
Making health care safer II: an updated critical analysis of the evidence for patient safety practices. Evid Rep Technol Assess (Full Rep) (2013) 1.49
The first step of glycosylphosphatidylinositol biosynthesis is mediated by a complex of PIG-A, PIG-H, PIG-C and GPI1. EMBO J (1998) 1.47
Mutations in the small heterodimer partner gene are associated with mild obesity in Japanese subjects. Proc Natl Acad Sci U S A (2001) 1.46